Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematologic Malignancies Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Services
1.2.3 Kits
1.3 Market by Application
1.3.1 Global Hematologic Malignancies Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Research Institutions
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematologic Malignancies Testing Market Perspective (2018-2033)
2.2 Hematologic Malignancies Testing Growth Trends by Region
2.2.1 Global Hematologic Malignancies Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hematologic Malignancies Testing Historic Market Size by Region (2018-2023)
2.2.3 Hematologic Malignancies Testing Forecasted Market Size by Region (2024-2033)
2.3 Hematologic Malignancies Testing Market Dynamics
2.3.1 Hematologic Malignancies Testing Industry Trends
2.3.2 Hematologic Malignancies Testing Market Drivers
2.3.3 Hematologic Malignancies Testing Market Challenges
2.3.4 Hematologic Malignancies Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematologic Malignancies Testing Players by Revenue
3.1.1 Global Top Hematologic Malignancies Testing Players by Revenue (2018-2023)
3.1.2 Global Hematologic Malignancies Testing Revenue Market Share by Players (2018-2023)
3.2 Global Hematologic Malignancies Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematologic Malignancies Testing Revenue
3.4 Global Hematologic Malignancies Testing Market Concentration Ratio
3.4.1 Global Hematologic Malignancies Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematologic Malignancies Testing Revenue in 2022
3.5 Hematologic Malignancies Testing Key Players Head office and Area Served
3.6 Key Players Hematologic Malignancies Testing Product Solution and Service
3.7 Date of Enter into Hematologic Malignancies Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematologic Malignancies Testing Breakdown Data by Type
4.1 Global Hematologic Malignancies Testing Historic Market Size by Type (2018-2023)
4.2 Global Hematologic Malignancies Testing Forecasted Market Size by Type (2024-2033)
5 Hematologic Malignancies Testing Breakdown Data by Application
5.1 Global Hematologic Malignancies Testing Historic Market Size by Application (2018-2023)
5.2 Global Hematologic Malignancies Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hematologic Malignancies Testing Market Size (2018-2033)
6.2 North America Hematologic Malignancies Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Hematologic Malignancies Testing Market Size by Country (2018-2023)
6.4 North America Hematologic Malignancies Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hematologic Malignancies Testing Market Size (2018-2033)
7.2 Europe Hematologic Malignancies Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Hematologic Malignancies Testing Market Size by Country (2018-2023)
7.4 Europe Hematologic Malignancies Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematologic Malignancies Testing Market Size (2018-2033)
8.2 Asia-Pacific Hematologic Malignancies Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Hematologic Malignancies Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Hematologic Malignancies Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hematologic Malignancies Testing Market Size (2018-2033)
9.2 Latin America Hematologic Malignancies Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Hematologic Malignancies Testing Market Size by Country (2018-2023)
9.4 Latin America Hematologic Malignancies Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematologic Malignancies Testing Market Size (2018-2033)
10.2 Middle East & Africa Hematologic Malignancies Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Hematologic Malignancies Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Hematologic Malignancies Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Invitae Corporation
11.1.1 Invitae Corporation Company Detail
11.1.2 Invitae Corporation Business Overview
11.1.3 Invitae Corporation Hematologic Malignancies Testing Introduction
11.1.4 Invitae Corporation Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.1.5 Invitae Corporation Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Hematologic Malignancies Testing Introduction
11.2.4 Bio-Rad Laboratories Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Sysmex Corporation
11.3.1 Sysmex Corporation Company Detail
11.3.2 Sysmex Corporation Business Overview
11.3.3 Sysmex Corporation Hematologic Malignancies Testing Introduction
11.3.4 Sysmex Corporation Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.3.5 Sysmex Corporation Recent Development
11.4 Laboratory Corporation of America Holdings
11.4.1 Laboratory Corporation of America Holdings Company Detail
11.4.2 Laboratory Corporation of America Holdings Business Overview
11.4.3 Laboratory Corporation of America Holdings Hematologic Malignancies Testing Introduction
11.4.4 Laboratory Corporation of America Holdings Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.4.5 Laboratory Corporation of America Holdings Recent Development
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Detail
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Hematologic Malignancies Testing Introduction
11.5.4 NeoGenomics Laboratories Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.5.5 NeoGenomics Laboratories Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Hematologic Malignancies Testing Introduction
11.6.4 Abbott Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 VYANTbio
11.7.1 VYANTbio Company Detail
11.7.2 VYANTbio Business Overview
11.7.3 VYANTbio Hematologic Malignancies Testing Introduction
11.7.4 VYANTbio Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.7.5 VYANTbio Recent Development
11.8 Adaptive Biotechnologies
11.8.1 Adaptive Biotechnologies Company Detail
11.8.2 Adaptive Biotechnologies Business Overview
11.8.3 Adaptive Biotechnologies Hematologic Malignancies Testing Introduction
11.8.4 Adaptive Biotechnologies Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.8.5 Adaptive Biotechnologies Recent Development
11.9 Asuragen Inc.
11.9.1 Asuragen Inc. Company Detail
11.9.2 Asuragen Inc. Business Overview
11.9.3 Asuragen Inc. Hematologic Malignancies Testing Introduction
11.9.4 Asuragen Inc. Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.9.5 Asuragen Inc. Recent Development
11.10 Invivoscribe, Inc.
11.10.1 Invivoscribe, Inc. Company Detail
11.10.2 Invivoscribe, Inc. Business Overview
11.10.3 Invivoscribe, Inc. Hematologic Malignancies Testing Introduction
11.10.4 Invivoscribe, Inc. Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.10.5 Invivoscribe, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hematologic Malignancies Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Services
Table 3. Key Players of Kits
Table 4. Global Hematologic Malignancies Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Hematologic Malignancies Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Hematologic Malignancies Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hematologic Malignancies Testing Market Share by Region (2018-2023)
Table 8. Global Hematologic Malignancies Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Hematologic Malignancies Testing Market Share by Region (2024-2033)
Table 10. Hematologic Malignancies Testing Market Trends
Table 11. Hematologic Malignancies Testing Market Drivers
Table 12. Hematologic Malignancies Testing Market Challenges
Table 13. Hematologic Malignancies Testing Market Restraints
Table 14. Global Hematologic Malignancies Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hematologic Malignancies Testing Market Share by Players (2018-2023)
Table 16. Global Top Hematologic Malignancies Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Testing as of 2022)
Table 17. Ranking of Global Top Hematologic Malignancies Testing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Hematologic Malignancies Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hematologic Malignancies Testing Product Solution and Service
Table 21. Date of Enter into Hematologic Malignancies Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hematologic Malignancies Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hematologic Malignancies Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Hematologic Malignancies Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Hematologic Malignancies Testing Revenue Market Share by Type (2024-2033)
Table 27. Global Hematologic Malignancies Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hematologic Malignancies Testing Revenue Market Share by Application (2018-2023)
Table 29. Global Hematologic Malignancies Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Hematologic Malignancies Testing Revenue Market Share by Application (2024-2033)
Table 31. North America Hematologic Malignancies Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Hematologic Malignancies Testing Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Hematologic Malignancies Testing Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Hematologic Malignancies Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Hematologic Malignancies Testing Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Hematologic Malignancies Testing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Hematologic Malignancies Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Hematologic Malignancies Testing Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Hematologic Malignancies Testing Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Hematologic Malignancies Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Hematologic Malignancies Testing Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Hematologic Malignancies Testing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Hematologic Malignancies Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Hematologic Malignancies Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Hematologic Malignancies Testing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Invitae Corporation Company Detail
Table 47. Invitae Corporation Business Overview
Table 48. Invitae Corporation Hematologic Malignancies Testing Product
Table 49. Invitae Corporation Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 50. Invitae Corporation Recent Development
Table 51. Bio-Rad Laboratories Company Detail
Table 52. Bio-Rad Laboratories Business Overview
Table 53. Bio-Rad Laboratories Hematologic Malignancies Testing Product
Table 54. Bio-Rad Laboratories Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 55. Bio-Rad Laboratories Recent Development
Table 56. Sysmex Corporation Company Detail
Table 57. Sysmex Corporation Business Overview
Table 58. Sysmex Corporation Hematologic Malignancies Testing Product
Table 59. Sysmex Corporation Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 60. Sysmex Corporation Recent Development
Table 61. Laboratory Corporation of America Holdings Company Detail
Table 62. Laboratory Corporation of America Holdings Business Overview
Table 63. Laboratory Corporation of America Holdings Hematologic Malignancies Testing Product
Table 64. Laboratory Corporation of America Holdings Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 65. Laboratory Corporation of America Holdings Recent Development
Table 66. NeoGenomics Laboratories Company Detail
Table 67. NeoGenomics Laboratories Business Overview
Table 68. NeoGenomics Laboratories Hematologic Malignancies Testing Product
Table 69. NeoGenomics Laboratories Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 70. NeoGenomics Laboratories Recent Development
Table 71. Abbott Company Detail
Table 72. Abbott Business Overview
Table 73. Abbott Hematologic Malignancies Testing Product
Table 74. Abbott Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. VYANTbio Company Detail
Table 77. VYANTbio Business Overview
Table 78. VYANTbio Hematologic Malignancies Testing Product
Table 79. VYANTbio Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 80. VYANTbio Recent Development
Table 81. Adaptive Biotechnologies Company Detail
Table 82. Adaptive Biotechnologies Business Overview
Table 83. Adaptive Biotechnologies Hematologic Malignancies Testing Product
Table 84. Adaptive Biotechnologies Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 85. Adaptive Biotechnologies Recent Development
Table 86. Asuragen Inc. Company Detail
Table 87. Asuragen Inc. Business Overview
Table 88. Asuragen Inc. Hematologic Malignancies Testing Product
Table 89. Asuragen Inc. Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 90. Asuragen Inc. Recent Development
Table 91. Invivoscribe, Inc. Company Detail
Table 92. Invivoscribe, Inc. Business Overview
Table 93. Invivoscribe, Inc. Hematologic Malignancies Testing Product
Table 94. Invivoscribe, Inc. Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 95. Invivoscribe, Inc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematologic Malignancies Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Hematologic Malignancies Testing Market Share by Type: 2022 VS 2033
Figure 3. Services Features
Figure 4. Kits Features
Figure 5. Global Hematologic Malignancies Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Hematologic Malignancies Testing Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. Hematologic Malignancies Testing Report Years Considered
Figure 12. Global Hematologic Malignancies Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Hematologic Malignancies Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Hematologic Malignancies Testing Market Share by Region: 2022 VS 2033
Figure 15. Global Hematologic Malignancies Testing Market Share by Players in 2022
Figure 16. Global Top Hematologic Malignancies Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Testing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Hematologic Malignancies Testing Revenue in 2022
Figure 18. North America Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Hematologic Malignancies Testing Market Share by Country (2018-2033)
Figure 20. United States Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Hematologic Malignancies Testing Market Share by Country (2018-2033)
Figure 24. Germany Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Hematologic Malignancies Testing Market Share by Region (2018-2033)
Figure 32. China Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Hematologic Malignancies Testing Market Share by Country (2018-2033)
Figure 40. Mexico Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Hematologic Malignancies Testing Market Share by Country (2018-2033)
Figure 44. Turkey Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Invitae Corporation Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 48. Sysmex Corporation Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 49. Laboratory Corporation of America Holdings Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 50. NeoGenomics Laboratories Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 51. Abbott Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 52. VYANTbio Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 53. Adaptive Biotechnologies Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 54. Asuragen Inc. Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 55. Invivoscribe, Inc. Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed